Annual Operating Expenses:
$791.68M+$33.50M(+4.42%)Summary
- As of today, ACAD annual total operating expenses is $791.68 million, with the most recent change of +$33.50 million (+4.42%) on December 31, 2024.
- During the last 3 years, ACAD annual operating expenses has risen by +$156.23 million (+24.59%).
- ACAD annual operating expenses is now at all-time high.
Performance
ACAD Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$211.46M+$6.82M(+3.33%)Summary
- As of today, ACAD quarterly total operating expenses is $211.46 million, with the most recent change of +$6.82 million (+3.33%) on June 30, 2025.
- Over the past year, ACAD quarterly operating expenses has increased by +$18.16 million (+9.40%).
- ACAD quarterly operating expenses is now -17.03% below its all-time high of $254.85 million, reached on September 30, 2023.
Performance
ACAD Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ACAD Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +4.4% | +9.4% |
| 3Y3 Years | +24.6% | +27.7% |
| 5Y5 Years | +39.9% | +40.2% |
ACAD Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +24.6% | -17.0% | +36.6% |
| 5Y | 5-Year | at high | +39.9% | -17.0% | +63.0% |
| All-Time | All-Time | at high | +4981.0% | -17.0% | +825.9% |
ACAD Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $211.46M(+3.3%) |
| Mar 2025 | - | $204.63M(-11.3%) |
| Dec 2024 | $791.68M(+4.4%) | $230.81M(+15.5%) |
| Sep 2024 | - | $199.90M(+3.4%) |
| Jun 2024 | - | $193.30M(+15.3%) |
| Mar 2024 | - | $167.67M(-5.9%) |
| Dec 2023 | $758.18M(+3.8%) | $178.21M(-30.1%) |
| Sep 2023 | - | $254.85M(+64.7%) |
| Jun 2023 | - | $154.74M(-9.2%) |
| Mar 2023 | - | $170.38M(-5.4%) |
| Dec 2022 | $730.66M(+15.0%) | $180.14M(+13.0%) |
| Sep 2022 | - | $159.44M(-3.7%) |
| Jun 2022 | - | $165.55M(-26.6%) |
| Mar 2022 | - | $225.53M(+30.5%) |
| Dec 2021 | $635.44M(-10.2%) | $172.85M(+21.0%) |
| Sep 2021 | - | $142.82M(-8.5%) |
| Jun 2021 | - | $156.03M(-8.6%) |
| Mar 2021 | - | $170.77M(+31.7%) |
| Dec 2020 | $707.79M(+25.0%) | $129.70M(-14.3%) |
| Sep 2020 | - | $151.27M(+0.3%) |
| Jun 2020 | - | $150.84M(-14.5%) |
| Mar 2020 | - | $176.41M(+18.1%) |
| Dec 2019 | $566.02M(+25.0%) | $149.39M(+8.6%) |
| Sep 2019 | - | $137.59M(+0.2%) |
| Jun 2019 | - | $137.34M(-7.0%) |
| Mar 2019 | - | $147.64M(+19.0%) |
| Dec 2018 | $452.92M(+12.0%) | $124.02M(+7.2%) |
| Sep 2018 | - | $115.74M(-1.6%) |
| Jun 2018 | - | $117.58M(+15.8%) |
| Mar 2018 | - | $101.53M(-8.6%) |
| Dec 2017 | $404.25M(+41.5%) | $111.12M(+11.4%) |
| Sep 2017 | - | $99.75M(+3.6%) |
| Jun 2017 | - | $96.29M(-5.4%) |
| Mar 2017 | - | $101.83M(+15.1%) |
| Dec 2016 | $285.74M(+76.2%) | $88.49M(+15.2%) |
| Sep 2016 | - | $76.82M(+7.8%) |
| Jun 2016 | - | $71.27M(+41.8%) |
| Mar 2016 | - | $50.26M(+10.3%) |
| Dec 2015 | $162.17M(+73.7%) | $45.56M(+16.8%) |
| Sep 2015 | - | $39.00M(-1.3%) |
| Jun 2015 | - | $39.50M(-2.6%) |
| Mar 2015 | - | $40.55M(+42.0%) |
| Dec 2014 | $93.35M(+136.7%) | $28.55M(+14.2%) |
| Sep 2014 | - | $24.99M(+15.1%) |
| Jun 2014 | - | $21.72M(+21.0%) |
| Mar 2014 | - | $17.96M(+47.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $39.44M(+52.9%) | $12.16M(+12.5%) |
| Sep 2013 | - | $10.81M(+18.1%) |
| Jun 2013 | - | $9.16M(+48.6%) |
| Mar 2013 | - | $6.16M(-9.6%) |
| Dec 2012 | $25.79M(+3.5%) | $6.82M(+183.3%) |
| Sep 2012 | - | $2.41M(-55.7%) |
| Jun 2012 | - | $5.43M(+233.1%) |
| Mar 2012 | - | $1.63M(-69.3%) |
| Dec 2011 | $24.92M(-7.8%) | $5.31M(+4.3%) |
| Sep 2011 | - | $5.09M(-6.1%) |
| Jun 2011 | - | $5.42M(-7.5%) |
| Mar 2011 | - | $5.86M(+120.1%) |
| Dec 2010 | $27.04M(-47.9%) | -$29.13M(-786.7%) |
| Sep 2010 | - | $4.24M(-1.3%) |
| Jun 2010 | - | $4.30M(-21.8%) |
| Mar 2010 | - | $5.50M(-25.9%) |
| Dec 2009 | $51.87M(-24.4%) | $7.42M(-15.4%) |
| Sep 2009 | - | $8.77M(-31.6%) |
| Jun 2009 | - | $12.82M(-15.5%) |
| Mar 2009 | - | $15.17M(+6.3%) |
| Dec 2008 | $68.57M(-2.3%) | $14.27M(+2.4%) |
| Sep 2008 | - | $13.94M(-26.8%) |
| Jun 2008 | - | $19.04M(+8.0%) |
| Mar 2008 | - | $17.64M(-5.7%) |
| Dec 2007 | $70.21M(+22.8%) | $18.70M(+4.5%) |
| Sep 2007 | - | $17.89M(+42.0%) |
| Jun 2007 | - | $12.60M(-6.3%) |
| Mar 2007 | - | $13.45M(-0.7%) |
| Dec 2006 | $57.19M(+22.3%) | $13.55M(-18.0%) |
| Sep 2006 | - | $16.52M(+28.4%) |
| Jun 2006 | - | $12.86M(+30.3%) |
| Mar 2006 | - | $9.87M(-4.5%) |
| Dec 2005 | $46.76M(+52.3%) | $10.34M(+48.7%) |
| Sep 2005 | - | $6.95M(+7.0%) |
| Jun 2005 | - | $6.49M(+12.0%) |
| Mar 2005 | - | $5.80M(-22.2%) |
| Dec 2004 | $30.70M(+45.4%) | $7.46M(+17.9%) |
| Sep 2004 | - | $6.32M(+7.4%) |
| Jun 2004 | - | $5.89M(-8.5%) |
| Mar 2004 | - | $6.43M(+94.0%) |
| Dec 2003 | $21.12M(+11.7%) | - |
| Sep 2003 | - | $3.32M(+14.2%) |
| Jun 2003 | - | $2.90M(-10.7%) |
| Mar 2003 | - | $3.25M |
| Dec 2002 | $18.90M(-0.5%) | - |
| Dec 2001 | $18.99M(+21.9%) | - |
| Dec 2000 | $15.58M | - |
FAQ
- What is ACADIA Pharmaceuticals Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. annual operating expenses year-on-year change?
- What is ACADIA Pharmaceuticals Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for ACADIA Pharmaceuticals Inc.?
- What is ACADIA Pharmaceuticals Inc. quarterly operating expenses year-on-year change?
What is ACADIA Pharmaceuticals Inc. annual total operating expenses?
The current annual operating expenses of ACAD is $791.68M
What is the all-time high annual operating expenses for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high annual total operating expenses is $791.68M
What is ACADIA Pharmaceuticals Inc. annual operating expenses year-on-year change?
Over the past year, ACAD annual total operating expenses has changed by +$33.50M (+4.42%)
What is ACADIA Pharmaceuticals Inc. quarterly total operating expenses?
The current quarterly operating expenses of ACAD is $211.46M
What is the all-time high quarterly operating expenses for ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. all-time high quarterly total operating expenses is $254.85M
What is ACADIA Pharmaceuticals Inc. quarterly operating expenses year-on-year change?
Over the past year, ACAD quarterly total operating expenses has changed by +$18.16M (+9.40%)